The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $41.36

Today's change-0.06 -0.14%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $41.36

Today's change-0.06 -0.14%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA down (U.S.)$0.06

Fresenius Medical Care AG & Co KGaA closed lower Thursday, dropping (U.S.)$0.06 or 0.14% to (U.S.)$41.36. Shares have lost 3.84% over the last five days, but have gained 11.36% over the last year to date. This security has outperformed the S&P 500 by 18.28% during the last year.

Key company metrics

  • Open(U.S.) $41.40
  • Previous close(U.S.) $41.42
  • High(U.S.) $41.49
  • Low(U.S.) $41.21
  • Bid / Ask-- / --
  • YTD % change+11.36%
  • Volume71,952
  • Average volume (10-day)234,148
  • Average volume (1-month)186,345
  • Average volume (3-month)149,623
  • 52-week range(U.S.) $32.40 to (U.S.) $44.34
  • Beta0.58
  • Trailing P/E23.94×
  • P/E 1 year forward22.91×
  • Forward PEG2.16×
  • Indicated annual dividend(U.S.) $0.43
  • Dividend yield1.04%
  • Trailing EPS(U.S.) $1.73
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.87%

Based on its net profit margin of 7.87%, Fresenius Medical Care AG & Co KGaA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.30%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue3,9604,3204,1133,835
Total other revenue--------
Total revenue3,9604,3204,1133,835
Gross profit1,1841,4141,2881,211
Total cost of revenue2,7762,9062,8252,623
Total operating expense3,4563,6573,5233,279
Selling / general / administrative655724670631
Research & development31313031
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)---110
Other operating expenses, total--------
Operating income504663590556
Interest income (expense), net non-operating-162-162-111-111
Gain (loss) on sale of assets--------
Other--------
Income before tax402546491458
Income after tax264403329281
Income tax, total138143162177
Net income210335271234
Total adjustments to net income--------
Net income before extra. items210335271234
Minority interest-55-67-58-47
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items210335271234
Inc. avail. to common incl. extra. items210335271234
Diluted net income210335271234
Dilution adjustment--------
Diluted weighted average shares305304303302
Diluted EPS excluding extraordinary itemsvalue per share0.691.100.890.77
Dividends per sharevalue per share0.000.530.000.00
Diluted normalized EPSvalue per share0.691.100.900.77